ArticleCureus2025
Outcomes of a Novel Percutaneous Achilles Tendon Repair Technique: A Retrospective Case Series.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe management of acute mid-substance Achilles tendon ruptures has shifted towards minimally invasive techniques to reduce soft tissue complications. However, many percutaneous repair methods require expensive, dedicated instrumentation or reusable devices with reprocessing needs. This study describes a novel percutaneous Achilles tendon repair technique using readily available disposable standard instruments (Achilles-tendon Soft Tissue Augmentation Regenerative Repair (A-STARR)) and evaluates its clinical outcomes.
methodsA retrospective case series was conducted involving 21 patients (18 male, 3 female) with confirmed acute mid-substance Achilles tendon ruptures. All underwent percutaneous repair using the A-STARR technique between July 2017 and May 2018. Patients were followed up for a minimum of 12 months (range: 12-25 months). Primary outcomes included complication rates, time to return to work, return to sport, and the Achilles Tendon Total Rupture Score (ATRS) at one year.
resultsNo wound infections, re-ruptures, or sural nerve injuries were observed. The mean time to return to work was 40 days (range: 30-92 days). 18 patients (85.7%) returned to their pre-injury sport at a mean of 6.5 months (range: 4-12 months). The mean ATRS at one-year follow-up was 83.1 (range: 70-95).
conclusionThe A-STARR percutaneous Achilles tendon repair using disposable standard instruments was safe and effective in this series, with no complications and good functional recovery. It may provide a practical and cost-efficient alternative for treating acute mid-substance ruptures, particularly where specialized equipment is unavailable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.